These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24196163)

  • 21. BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.
    Henssen A; Thor T; Odersky A; Heukamp L; El-Hindy N; Beckers A; Speleman F; Althoff K; Schäfers S; Schramm A; Sure U; Fleischhack G; Eggert A; Schulte JH
    Oncotarget; 2013 Nov; 4(11):2080-95. PubMed ID: 24231268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT.
    Asuthkar S; Nalla AK; Gondi CS; Dinh DH; Gujrati M; Mohanam S; Rao JS
    Neuro Oncol; 2011 Oct; 13(10):1059-73. PubMed ID: 21813510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
    Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
    Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells.
    Masurkar SA; Deogharkar A; Bharambe HS; Shirsat NV
    Biochem Biophys Res Commun; 2021 Sep; 568():76-82. PubMed ID: 34192607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
    Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
    Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
    Chang Q; Chen Z; You J; McNutt MA; Zhang T; Han Z; Zhang X; Gong E; Gu J
    J Neurooncol; 2007 Sep; 84(3):263-7. PubMed ID: 17453147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma.
    Veo B; Danis E; Pierce A; Wang D; Fosmire S; Sullivan KD; Joshi M; Khanal S; Dahl N; Karam S; Serkova N; Venkataraman S; Vibhakar R
    Cell Rep; 2021 Apr; 35(4):109013. PubMed ID: 33910002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification.
    Ćwiek P; Leni Z; Salm F; Dimitrova V; Styp-Rekowska B; Chiriano G; Carroll M; Höland K; Djonov V; Scapozza L; Guiry P; Arcaro A
    Oncotarget; 2015 Jan; 6(1):116-29. PubMed ID: 25402633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.
    Bharambe HS; Paul R; Panwalkar P; Jalali R; Sridhar E; Gupta T; Moiyadi A; Shetty P; Kazi S; Deogharkar A; Masurkar S; Yogi K; Kunder R; Gadewal N; Goel A; Goel N; Chinnaswamy G; Ramaswamy V; Shirsat NV
    Acta Neuropathol Commun; 2019 Apr; 7(1):52. PubMed ID: 30944042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.
    von Bueren AO; Shalaby T; Oehler-Jänne C; Arnold L; Stearns D; Eberhart CG; Arcaro A; Pruschy M; Grotzer MA
    BMC Cancer; 2009 Jan; 9():10. PubMed ID: 19134217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
    BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
    Cohen JR; Resnick DZ; Niewiadomski P; Dong H; Liau LM; Waschek JA
    BMC Cancer; 2010 Dec; 10():676. PubMed ID: 21143927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas?
    Sengupta S; Weeraratne SD; Cho YJ; Pomeroy SL
    CNS Oncol; 2014 Jul; 3(4):245-7. PubMed ID: 25286034
    [No Abstract]   [Full Text] [Related]  

  • 36. An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.
    Lal S; Carrera D; Phillips JJ; Weiss WA; Raffel C
    Neuro Oncol; 2018 Nov; 20(12):1606-1615. PubMed ID: 29912438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
    Thompson EM; Whitney NL; Wu YJ; Neuwelt EA
    J Neurosurg Pediatr; 2013 Jan; 11(1):60-7. PubMed ID: 23082872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDM2 promotes WIP1-mediated medulloblastoma growth.
    Buss MC; Read TA; Schniederjan MJ; Gandhi K; Castellino RC
    Neuro Oncol; 2012 Apr; 14(4):440-58. PubMed ID: 22379189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.
    Burger MC; Brucker DP; Baumgarten P; Ronellenfitsch MW; Wanka C; Hasselblatt M; Eccles MR; Klingebiel T; Weller M; Rieger J; Mittelbronn M; Steinbach JP
    Int J Oncol; 2012 Jul; 41(1):235-41. PubMed ID: 22552444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse model of the most aggressive subgroup of human medulloblastoma.
    Kawauchi D; Robinson G; Uziel T; Gibson P; Rehg J; Gao C; Finkelstein D; Qu C; Pounds S; Ellison DW; Gilbertson RJ; Roussel MF
    Cancer Cell; 2012 Feb; 21(2):168-80. PubMed ID: 22340591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.